Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Cell adhesion molecules are important in the development of certain skin diseases.

The treatment helped regrow hair in people with androgenetic alopecia.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Upadacitinib improved multiple immune-related conditions in one patient.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Human thymus has stem cells that can self-renew and maintain their identity.

Arg1+ macrophages may play a role in causing alopecia areata.

Collagen XVII and CD151 affect cell movement, with CD151 inhibiting migration when bound to integrins.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Human hair follicle stem cells can be enriched by sticking to type IV collagen.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

A specific gene change is linked to severe hair loss.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.